OOIR: Observatory of International Research

Papers

(The TQCC of Current Hypertension Reports is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Inverse Salt Sensitivity of Blood Pressure: Mechanisms and Potential Relevance for Prevention of Cardiovascular Disease	187
Role of Inflammatory Processes in the Brain-Body Relationship Underlying Hypertension	101
Urinary Biomarkers Of Kidney Function As Predictors Of Cardiovascular Health: A Systematic Review	80
Hypertension, Obesity, and Target Organ Injury in Children: An Emerging Health Care Crisis	78
Role of Female Sex Hormones and Immune Response in Salt-Sensitive Hypertension Development: Evidence from Experimental Models	55
Refractory Hypertension: a Narrative Systematic Review with Emphasis on Prognosis	47
Pet Ownership and the Risk of Arterial Hypertension and Cardiovascular Disease	46
Sodium Intake and Risk of Hypertension: A Systematic Review and Dose–Response Meta-analysis of Observational Cohort Studies	45
Does Renal Denervation a Reasonable Treatment Option in Hemodialysis-Dependent Patient with Resistant Hypertension? A Narrative Review	44
A Critical Role for the Paraventricular Nucleus of the Hypothalamus in the Regulation of the Volume Reflex in Normal and Various Cardiovascular Disease States	43
Approach to Endocrine Hypertension: A Case-Based Discussion	36
Effect of Different Classes of Antihypertensive Drugs on Arterial Stiffness	35
Remote Blood Pressure Monitoring in Pregnancies at Risk of Developing Preeclampsia	34
Integrated Care Model of Adiposity-Related Chronic Diseases	33
Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition	31
Management of Pulmonary Hypertension in the Context of Heart Failure with Preserved Ejection Fraction	31
Gut Microbiota and Its Role in the Brain-Gut-Kidney Axis in Hypertension	30
Cardiovascular Dysfunction in Intrauterine Growth Restriction	26
HEARTS in the Americas: Targeting Health System Change to Improve Population Hypertension Control	23
Secondary Hypertension in Children—Identifying and Investigating at Risk Children	23
Firibastat: a Novel Treatment for Hypertension	23
Sodium-Directed Crosstalk Between Immune Cells and Lymphatic Vessels	21
Blood Pressure Assessment and Treatment in the Observation Unit	21
Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease	21
Sex Difference of Alcoholic Hypertension: Mechanism and Targeted Therapy	20

Detecting and Managing Childhood Onset Hypertension in Africa: A Call to Action	20
A Systematic Review of the Role of Telemedicine in Blood Pressure Control: Focus on Patient Engagement	19
Clinical Significance of Nocturnal Hypertension and Nighttime Blood Pressure Dipping in Hypertension	18
Sympathetic Nervous System in Heart Failure: Targets for Treatments	18
Effects of Puberty on Blood Pressure Trajectories — Underlying Processes	17
Lipoprotein (a) and Hypertension	17
The Burden of Resistant Hypertension Across the World	17
Beneficial Effects of Exercise on Hypertension-Induced Cardiac Hypertrophy in Adolescents and Young Adults	16
Interpreting High-Sensitive Troponins in Patients with Hypertension	16
Is Vitamin D Supplementation an Effective Treatment for Hypertension?	15
Use of Self-Measured Blood Pressure Monitoring to Improve Hypertension Equity	15
Salt Taste and Salt Sensitive Hypertension in HIV	15
Mitochondrial Dysfunction in the Pathogenesis of Preeclampsia	15
White Coat Hypertension & Cardiovascular Outcomes	14
Resistant Hypertension: Disease Burden and Emerging Treatment Options	14
Importance of the (Pro)renin Receptor in Activating the Renin-Angiotensin System During Normotensive and Preeclamptic Pregnancies	14
Standardizing Blood Pressure Measurements in Pediatric Hemodialysis: a Collaborative Journey	14
Six Decades of History of Hypertension Research at the University of Toledo: Highlighting Pioneering Contributions in Biochemistry, Genetics, and Host-Microbiota Interactions	14
Underlying Mechanisms and Treatment of Hypertension in Glomerular Diseases	14
The Time to Reconsider Mineralocorticoid Receptor Blocking Strategy: Arrival of Nonsteroidal Mineralocorticoid Receptor Blockers	14
Sex Differences in the Prevalence, Outcomes and Management of Hypertension	14